Your browser doesn't support javascript.
loading
Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge.
Herz-Roiphe, R; Kim, A Y; Kaimal, A J; Goldfarb, I T.
Affiliation
  • Herz-Roiphe R; Harvard Medical School, Boston, MA, USA. Electronic address: rachel_herz-roiphe@hms.harvard.edu.
  • Kim AY; Harvard Medical School, Boston, MA, USA; Department of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA.
  • Kaimal AJ; Harvard Medical School, Boston, MA, USA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA.
  • Goldfarb IT; Harvard Medical School, Boston, MA, USA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA.
J Hosp Infect ; 129: 38-40, 2022 11.
Article in En | MEDLINE | ID: mdl-35944789
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: J Hosp Infect Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: J Hosp Infect Year: 2022 Document type: Article Country of publication: